ÍslenskaenEnglish

Aðilar að Skemmunni

Leit eftir:


LokaverkefniHáskóli Íslands>Heilbrigðisvísindasvið>B.S. verkefni>

Vinsamlegast notið þetta auðkenni þegar þið vitnið til verksins eða tengið í það: http://hdl.handle.net/1946/21511

Titlar
  • en

    Anticoagulation variability in relation to occurrence of thromboembolism and clinically relevant bleeding in patients on warfarin monitored with either Fiix-prothrombin time or Quick-prothrombin time

  • Samband breytileika warfarínmeðferðar við blóðsegamyndun og blæðingar hjá sjúklingum sem stýrt er með Fiix-próþrombíntíma eða Quick-próþrombíntíma

Skilað
Maí 2015
Útdráttur
en

Introduction: Warfarin is challenging in use and its effect must be carefully monitored to maintain the desired anticoagulation level. The Quick prothrombin time (PT) is most commonly used to monitor the warfarin effect by measuring the effect of changes in coagulation factors (F) II, VII and X on the clotting time. Experiments suggest that rapid fluctuations in factor VII activity, mainly due to its short half-life, contribute to variation in the measured clotting time but less to the antithrombotic effect itself. The newly developed Fiix prothrombin time (Fiix-PT) is only sensitive to factors II and X and has been shown to improve anticoagulation stability. The objective of the current study is to estimate anticoagulation variability in relation to the occurrence of thromboembolic events and bleeding in patients monitored with Fiix-PT or PT.

Samþykkt
13.5.2015


Skrár
NafnRaðanlegtStærðRaðanlegtAðgangurRaðanlegtLýsingRaðanlegtSkráartegund
AlmaRut_BS.pdf1,01MBLæst til  1.7.2017 Heildartexti PDF